CLEVELAND, May 28, 2015 /PRNewswire/ -- DATATRAK International, Inc. (OTCQX: DTRK), the leader in developing cloud-based, unified dClinical™ technologies and delivering related services for the clinical trials industry, today announced that its Chairman and CEO, Mr. Laurence P. Birch, will present at the LD Micro Invitational on June 3, 2015, at 9:00am PST / 12:00pm EST, in Los Angeles.
"DATATRAK has long been at the forefront of technology and its application in clinical research," said Laurence P. Birch, Chairman and CEO, DATATRAK. "Advancements in digital technology, including Cloud, Data Analytics and Mobile accessibility, require a platform that can leverage this functionality to simplify clinical research. Our unified digital platform uniquely delivers the transformative power of the evolution of digital, ushering in the next generation solution for researchers around the world: the unified dClinical™ platform."
"Powered by our unified dClinical™ platform, users put an end to painful mid-study changes and long wait times for reporting. As a result, more and more organizations are choosing DATATRAK."
"The LD Micro Invitational is a great opportunity for investors to learn more about DATATRAK," said Birch. "Our combination of life science experience and expertise in technology delivers a truly differentiated solution – a unified digital platform - to clinical research. We look forward to continuing to drive awareness and interest among our institutional and retail investors."
Join DATATRAK Thought Leaders:
DATATRAK International is a worldwide technology and services company delivering unified eClinical® solutions and related services for the clinical trials industry. DATATRAK built its multi-component, comprehensive solution on a single, unified platform and expanded this concept to include services delivery via DATATRAK's Clinical and Consulting Services group. The Company delivers a complete portfolio of software products designed to accelerate the reporting of clinical research data from sites to sponsors and ultimately regulatory authorities, faster and more efficiently than loosely integrated technologies. The DATATRAK ONE® software solution, deployed worldwide through an ASP or Enterprise Transfer offering, supports Preclinical and Phase I - Phase IV drug and device studies in multiple languages throughout the world. DATATRAK is located in Chicago, Illinois; Cleveland, Ohio; Bryan, Texas; Cary (RTP), North Carolina; and Plymouth, Minnesota. For more information, visit http://www.datatrak.com.
Except for the historical information contained in this press release, the statements made in this release are forward-looking statements. These forward-looking statements are made based on management's expectations, assumptions, estimates and current beliefs concerning the operations, future results and prospects of the Company and are subject to uncertainties and factors which are difficult to predict and, in many instances, are beyond the control of the Company, and which could cause actual results to differ materially from those contemplated in these forward-looking statements. For a list of certain factors that may cause actual results to differ materially from those contemplated in these forward looking statements, please see the Company's report filed with the OTCQX Market on March 13, 2015 announcing its results for the full-year period ended December 31, 2014. The Company undertakes no obligation to update publicly or revise any forward-looking statement whether as a result of new information, future events or otherwise.
About LD Micro
LD Micro is an investment newsletter firm that focuses on finding undervalued companies in the micro-cap space. Since 2002, the firm has published reports on select companies throughout the year. The firm also hosts the LD Micro Main Event in December. It is a non-registered investment advisor. For more information, please contact 408-457-1042 or visit www.ldmicro.com.
SOURCE DATATRAK International, Inc.